Cancer Immunotherapy
Dr. Zhao Chen
Dr. Pin Zhao
Special Issue Information
Dear Colleagues,
Research on cancer immunotherapy holds immense significance in the field of oncology and has revolutionized the way we approach cancer treatment. Understanding the mechanisms of immune response to cancer and developing effective immunotherapeutic strategies can potentially lead to targeted treatments with fewer side effects and enhanced long-term survival rates. Immune checkpoint inhibitors, adoptive cell therapy, cancer vaccines, and combination therapies have emerged as groundbreaking modalities, providing promising results and transforming the landscape of cancer care.
Moreover, studying the tumor immunology and immune microenvironment is crucial for unraveling the complexities of cancer progression, identifying biomarkers, and developing personalized treatment approaches. Immune evasion mechanisms employed by tumors present critical challenges that require innovative strategies to overcome.
The continuous advancement of cancer immunotherapy research not only improves patient outcomes but also opens new avenues for precision medicine and interdisciplinary collaborations. It offers potential breakthro-ughs in understanding the interplay between the immune system and cancer cells, paving the way for novel therapeutic targets and approaches.
The Special Issue on "Cancer Immunotherapy" explores the rapidly advance-ing field of immunotherapy and its potential as a transformative approach in cancer treatment. We invite to submit the original research papers, case reports, clinical trials, and review articles with various aspects of cancer immunotherapy, including emerging immunotherapeutic approachhes, novel therapeutic targets, immune checkpoint inhibitors, adoptive cell therapies, and combination therapies. Furthermore, it explores the latest advancements in understanding the mechanisms of immune evasion and resistance to immunotherapy, as well as strategies to overcome these challenges.